Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
Aims. Metformin is an oral antidiabetic agent that has been widely prescribed for the treatment of type II diabetes. In recent years, anticancer properties of metformin have been revealed for numerous human malignancies. However, there are few indications available regarding the feasibility and safe...
Guardado en:
Autores principales: | Jinqing Wu, Yabo Zhou, Guizhou Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b000af68ed84b8886381602799821d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging
por: Yeun‐Yoon Kim, et al.
Publicado: (2021) -
Drug-induced liver injury: Advances and confusions in treatment
por: CHEN Shuai
Publicado: (2021) -
Adenocarcinoma with Mixed Subtypes in the Early and Advanced Gastric Cancer
por: Xixian Zhao, et al.
Publicado: (2021) -
Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions
por: Mehrotra S, et al.
Publicado: (2020) -
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis N, et al.
Publicado: (2021)